← Back

Priothera πŸ‡«πŸ‡·

Series A

Immune modulator to improve outcomes of allogeneic stem cell transplantation in blood cancers. Saint-Louis, France.

About Priothera

Priothera is a France-based company founded in 2019, now around 30 people.

Founded by Florent Gros (CEO & Founder; previously NestlΓ©, Novartis; kaufmann MBA), Dr. Simone Seiter (Co-Founder; previously Capgemini Management Consulting (Life Sciences /Healthcare), DKFZ German Cancer Research Center), Christoph Bucher (Co-Founder; previously Novartis, Roche; University of Basel).

Its investors also appear on FundFinder's most-active lists for Series A Β· Healthcare & Wellbeing (54 funds), Series A Β· Life Sciences (20 funds).

Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.

Want the latest on Priothera? Our research agent pulls the current description, latest round and full investor base from public sources (about a minute).

Series A Β· Sep 2025

InvestorsHealthCap
  • HealthCap β€” HealthCap is a life sciences venture investor and company creator based in Stockholm and founded in 1996.
Raising your own round? See which European funds fit β†’